1. Search Result
Search Result
Targets Recommended: GPR109A
Results for "

1952272-74-0

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-P99010
    Bemarituzumab

    FGFR Cancer
    Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research.